Grantham, Mayo, Van Otterloo & Co (GMO)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.25M Buy
28,600
+6,800
+31% +$315K ﹤0.01% 509
2026
Q2
$930K Buy
21,800
+6,800
+45% +$369K ﹤0.01% 525
2026
Q1
$941K Buy
+15,000
New +$1.2M ﹤0.01% 513
2020
Q2
– Sell
-103,938
Closed -$3.39M – 758
2020
Q1
$3.39M Buy
+103,938
New +$4.06M 0.03% 306
2014
Q1
– Sell
-78,020
Closed -$938K – 572
2013
Q4
$938K Buy
+78,020
New +$922K ﹤0.01% 461

Other funds holding BSX

Grantham, Mayo, Van Otterloo & Co (GMO)'s BSX Position: Q3 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Boston Scientific (BSX) stake by 31% in Q3 2026, buying an estimated $315K and bringing the position to 28,600 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #509.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in BSX in Q4 2013 and has held it in 5 quarters since. The position peaked at $3.39M in Q1 2020. 1,515 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 28,600 shares of Boston Scientific worth $1.25M as of Q3 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 6,800 Boston Scientific shares in Q3 2026, an estimated $315K.
  • Boston Scientific made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q3 2026, its #509 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Boston Scientific in Q4 2013 and has held it in 5 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Boston Scientific position peaked at $3.39M in Q1 2020.
  • 1,515 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2026, filed 13 Nov 2026.